[1] |
Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology Guidelines on Renal Cell Carcinoma:The 2022 Update[J]. Eur Urol, 2022, 82(4):399-410.
doi: 10.1016/j.eururo.2022.03.006
pmid: 35346519
|
[2] |
Spyropoulou D, Tsiganos P, Dimitrakopoulos FI, et al. Radiotherapy and renal cell carcinoma:A continuing saga[J]. In Vivo, 2021, 35(3):1365-1377.
doi: 10.21873/invivo.12389
pmid: 33910814
|
[3] |
Santana T, Custódio M, DaylaMelo Oliveira C, et al. Parotid metastasis of clear cell renal cell carcinoma 8 years after nephrectomy[J]. Oral Oncol, 2021, 122:105561.
doi: 10.1016/j.oraloncology.2021.105561
|
[4] |
Gopan G, Kamala LH, Radhakrishnan N. Renal cell carcinoma presenting as bulky parotid massacase report and review of literature[J]. Indian J Surg Oncol, 2021, 12(2):378-382.
|
[5] |
Lieder A, Guenzel T, Lebentrau S, et al. Diagnostic relevance of metastatic renal cell carcinoma in the head and neck:An evaluation of 22 cases in 671 patients[J]. Int Braz J Urol, 2017, 43(2):202-208.
doi: 10.1590/S1677-5538.IBJU.2015.0665
pmid: 27649110
|
[6] |
Ading H, Huimin L, Huasheng L, et al. Metastatic parotid gland malignancy:A preliminary study in an eastern Chinese population[J]. J Stomatol Oral Maxillofac Surg, 2023, 124(2):101309.
doi: 10.1016/j.jormas.2022.10.008
|
[7] |
Franzen AM, Günzel T, Lieder A. Parotid gland metastases of distant primary tumours:A diagnostic challenge[J]. Auris Nasus Larynx, 2016, 43(2):187-191.
doi: 10.1016/j.anl.2015.09.010
pmid: 26526643
|
[8] |
Danić P, Danić D, Macan D. Tongue metastasis as an initial presentation of renal cell carcinoma[J]. Med Glas (Zenica),2018,15(1):52-58.
|
[9] |
Nisi M, Izzetti R, Graziani F, et al. Renal cell carcinoma metastases to the oral cavity:Report of 2 cases and review of literature[J]. J Oral Maxillofac Surg, 2020, 78(9):1557-1571.
doi: 10.1016/j.joms.2020.04.001
|
[10] |
Majewska H, Skálová A, Radecka K, et al. Renal clear cell carcinoma metastasis to salivary glands a series of 9 cases:Clinico-pathological study[J]. Pol J Pathol, 2016, 67(1):39-45.
pmid: 27179273
|
[11] |
Morita Y, Kashima K, Suzuki M, et al. Differential diagnosis between oral metastasis of renal cell carcinoma and salivary gland cancer[J]. Diagnostics (Basel), 2021, 11(3):506.
|
[12] |
Kar A, Pattnaik K, Kar T, et al. Clear cell lesions in pathology:Histomorphologic approach to diagnosis[J]. Indian J Pathol Microbiol, 2020, 63(2):177-187.
doi: 10.4103/IJPM.IJPM_791_19
|
[13] |
Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions[J]. Clin Orthop Relat Res, 1986(205):299-308.
|
[14] |
Tajima S, Namiki I, Koda K. A clear cell variant of mucoepidermoid carcinoma harboring CRTC1-MAML2 fusion gene found in buccal mucosa:Report of a case showing a large clear cell component and lacking typical epidermoid cells and intermediate cells[J]. Med Mol Morphol, 2017, 50(2):117-121.
doi: 10.1007/s00795-015-0120-5
pmid: 26297211
|
[15] |
Gomes PS, Fernandes MH. Rodent models in bone-related research:The relevance of calvarial defects in the assessment of bone regeneration strategies[J]. Lab Anim, 2011, 45(1):14-24.
|
[16] |
Zirong C, Ni W, Jian-Liang L, et al. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma[J]. JCI Insight, 2021, 6(7):e139497.
|
[17] |
Daoud EV, McLean-Holden AC, Pfeifer CM, et al. Pediatric warthin-like mucoepidermoid carcinoma:Report of two cases with one persistent/recurrent as conventional mucoepidermoid carcinoma[J]. Head Neck Pathol, 2020, 14(4):923-928.
doi: 10.1007/s12105-020-01156-w
|
[18] |
Sakamoto S, Miyauchi M, Ando T, et al. Non-sebaceous lymphadenoma-like mucoepidermoid carcinoma:A case report[J]. Pathol Int, 2022, 72(7):371-375.
doi: 10.1111/pin.v72.7
|
[19] |
Peiffer BJ, Qi L, Ahmadi AR, et al. Activation of BMP signaling by FKBP12 ligands synergizes with inhibition of CXCR4 to accelerate wound healing[J]. Cell Chem Biol, 2019, 26(5):652-661.
doi: S2451-9456(19)30033-9
pmid: 30827938
|
[20] |
Haller F, Bieg M, Will R, et al. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands[J]. Nat Commun, 2019, 10(1):368.
doi: 10.1038/s41467-018-08069-x
pmid: 30664630
|
[21] |
Viswanathan K, Beg S, He B, et al. NR4A3 immunostainis a highly sensitive and specific marker for aciniccell carcinoma in cytologic and surgical specimens[J]. Am J Clin Pathol, 2022, 157(1):98-108.
doi: 10.1093/ajcp/aqab099
|
[22] |
Katsuno-Kambe H, Teo JL, Ju RJ, et al. Collagen polarization promotes epithelial elongation by stimulating locoregional cell proliferation[J]. eLife, 2021, 10:e67915.
|
[23] |
Corps K, Stanwick M, Rectenwald J, et al. Skeletal deformities in osterix-Cre; Tgfbr2f/fmice may cause postnatal death[J]. Genes, 2021, 12(7):975.
doi: 10.3390/genes12070975
|
[24] |
McHugh JB, Hoschar AP, Dvorakova M, et al. p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma[J]. Head Neck Pathol, 2007, 1(2):123-131.
doi: 10.1007/s12105-007-0031-4
pmid: 20614263
|
[25] |
Gubbiotti MA, Montone K, Zhang P, et al. A contemporary update on hyalinizing clear cell carcinoma:Compilation of all in-house cases at our institution and a literature review spanning 2015—2020[J]. Hum Pathol, 2021, 111:45-51.
doi: 10.1016/j.humpath.2021.01.007
pmid: 33577927
|
[26] |
Franzen AM, Glitzky S, Moganti A, et al. Metastases to both parotid glands six and twelve years after resection of renal cell carcinoma[J]. Case Rep Med, 2018, 2018:7301727.
|
[27] |
Yatabe Y, Dacic S, Borczuk AC, et al. Best practices recommendations for diagnostic immunohistochemistry in lung cancer[J]. J Thorac Oncol, 2019, 14(3):377-407.
doi: S1556-0864(18)33514-7
pmid: 30572031
|
[28] |
Du T, Pan L, Chengyou Z, et al. Matrix Gla protein (MGP), GATA3, and TRPS1:A novel diagnostic panel to determine breast origin[J]. Breast Cancer Res, 2022, 24(1):70.
doi: 10.1186/s13058-022-01569-1
|
[29] |
Wu CE, Tzen CY, Wang SY, et al. Clinical diagnosis of gastrointestinal stromal tumor (GIST):From the molecular genetic point of view[J]. Cancers, 2019, 11(5):679.
doi: 10.3390/cancers11050679
|
[30] |
Danfeng L, Lesang S, Meng L, et al. Circulating tumor cells:Biology and clinical significance[J]. Signal Transduct Target Ther, 2021, 6(1):404.
|
[31] |
Khalil BD, Sanchez R, Rahman T, et al. An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy[J]. J Exp Med, 2022, 219(1):e20210836.
|